Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct 9;20(20):4976.
doi: 10.3390/ijms20204976.

Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases

Affiliations
Review

Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases

Anastasiia Bohush et al. Int J Mol Sci. .

Abstract

Proper folding is crucial for proteins to achieve functional activity in the cell. However, it often occurs that proteins are improperly folded (misfolded) and form aggregates, which are the main hallmark of many diseases including cancers, neurodegenerative diseases and many others. Proteins that assist other proteins in proper folding into three-dimensional structures are chaperones and co-chaperones. The key role of chaperones/co-chaperones is to prevent protein aggregation, especially under stress. An imbalance between chaperone/co-chaperone levels has been documented in neurons, and suggested to contribute to protein misfolding. An essential protein and a major regulator of protein folding in all eukaryotic cells is the heat shock protein 90 (Hsp90). The function of Hsp90 is tightly regulated by many factors, including co-chaperones. In this review we summarize results regarding the role of Hsp90 and its co-chaperones in neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and prionopathies.

Keywords: Alzheimer’s disease; Hsp90; Hsp90 inhibitors; Huntington’s disease; Parkinson’s disease; co-chaperones; prionopathy.

PubMed Disclaimer

Conflict of interest statement

The Authors declare no conflict of interest.

References

    1. Ciechanover A., Kwon Y.T. Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies. Exp. Mol. Med. 2015;47:e147. doi: 10.1038/emm.2014.117. - DOI - PMC - PubMed
    1. Cuanalo-Contreras K., Mukherjee A., Soto C. Role of protein misfolding and proteostasis deficiency in protein misfolding diseases and aging. Int. J. Cell Biol. 2013;2013:638083. doi: 10.1155/2013/638083. - DOI - PMC - PubMed
    1. Pace M.C., Xu G., Fromholt S., Howard J., Crosby K., Giasson B.I., Lewis J., Borchelt D.R. Changes in proteome solubility indicate widespread proteostatic disruption in mouse models of neurodegenerative disease. Acta. Neuropathol. 2018;136:919–938. doi: 10.1007/s00401-018-1895-y. - DOI - PMC - PubMed
    1. Garrido C., Gurbuxani S., Ravagnan L., Kroemer G. Heat shock proteins: Endogenous modulators of apoptotic cell death. Biochem. Biophys. Res. Commun. 2001;286:433–442. doi: 10.1006/bbrc.2001.5427. - DOI - PubMed
    1. Castro J.P., Wardelmann K., Grune T., Kleinridders A. Mitochondrial Chaperones in the Brain: Safeguarding Brain Health and Metabolism? Front Endocrinol. (Lausanne) 2018;9:196. doi: 10.3389/fendo.2018.00196. - DOI - PMC - PubMed

MeSH terms